Cancer risk assessment: Optimizing human health through linear dose-response models.

Area of Science:

• Toxicology
• Radiation Oncology
• Risk Assessment

Background:

• Current cancer risk assessments often rely on the Linear Non-Threshold (LNT) model.
• Hormetic dose-response models suggest beneficial effects at low doses.
• Integrating these models presents a challenge for accurate risk prediction.

Purpose of the Study:

• To propose a novel approach for cancer risk assessment by integrating LNT and hormetic dose-response models.
• To identify an optimal dose level for risk assessment that balances protection and potential benefit.
• To address limitations in validating risk models with human population or standard animal data.

Main Methods:

• Integration of the Linear Non-Threshold (LNT) model with hormetic dose-response principles.
• Estimation of optimal hormetic beneficial responses at a 10(-4) risk level derived from LNT application to animal cancer studies.
• Theoretical and practical analysis of model integration for risk assessment.

Main Results:

• The proposed integrated model suggests optimal hormetic benefits occur at a dose associated with a 10(-4) risk level.
• This integration provides a "regulatory sweet spot" for toxicologically based risk assessment.
• The model demonstrates the functional utility of the LNT model for population protection while allowing for potential cancer incidence reduction.

Conclusions:

• Integrating LNT and hormetic models offers a more comprehensive approach to cancer risk assessment.
• The 10(-4) risk level serves as a theoretically sound and practically applicable benchmark.
• This approach reconciles competing risk assessment models and enhances toxicological risk management strategies.